| |
| |
|
| Insider
Information: |
Mcgrath John |
| Relationship: |
EVP & Chief Financial ... |
| City: |
Fremont |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
108,631 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$47,035 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
108,631 |
|
|
| Total
Value |
$47,035 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Endwave Corp |
ENWV |
Director |
2005-07-29 |
0 |
2005-07-29 |
0 |
Premium* |
|
|
Network Equipment Technologies Inc |
NWK |
EXC.112.VP CFO |
2009-11-05 |
19,869 |
2006-05-05 |
0 |
Premium* |
|
|
Atara Biotherapeutics, Inc. |
ATRA |
EVP & Chief Financial ... |
2018-03-20 |
88,762 |
2015-01-16 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
76 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NWK |
Network Equipment Technol... |
CFO |
• – – |
2006-05-05 |
4 |
A |
$0.00 |
$15 |
D/D |
15,000 |
15,000 |
|
- |
|
| NWK |
Network Equipment Technol... |
CFO |
• – – |
2006-11-06 |
4 |
D |
$5.78 |
$3,878 |
D/D |
(671) |
18,658 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Financial Officer |
• – – |
2015-01-16 |
4 |
A |
$0.00 |
$0 |
D/D |
12,400 |
12,400 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Financial Officer |
• – – |
2015-05-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
65,357 |
77,757 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Financial Officer |
• – – |
2015-05-15 |
4 |
D |
$37.30 |
$1,134,107 |
D/D |
(30,405) |
47,352 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Financial Officer |
• – – |
2015-05-29 |
4 |
AS |
$40.00 |
$400,000 |
D/D |
(10,000) |
37,352 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Financial Officer |
• – – |
2015-06-15 |
4 |
AS |
$50.00 |
$500,000 |
D/D |
(10,000) |
27,352 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Financial Officer |
• – – |
2015-08-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,502 |
37,854 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Financial Officer |
• – – |
2015-08-18 |
4 |
AS |
$49.38 |
$296,280 |
D/D |
(6,000) |
31,854 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Financial Officer |
• – – |
2015-11-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,502 |
42,356 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Financial Officer |
• – – |
2015-11-30 |
4 |
AS |
$40.00 |
$240,000 |
D/D |
(6,000) |
36,356 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Financial Officer |
• – – |
2016-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
42,857 |
79,213 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Financial Officer |
• – – |
2016-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,501 |
89,714 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Financial Officer |
• – – |
2016-02-16 |
4 |
AS |
$15.49 |
$92,940 |
D/D |
(6,000) |
83,714 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Financial Officer |
• – – |
2016-05-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,503 |
94,217 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Financial Officer |
• – – |
2016-05-16 |
4 |
AS |
$15.77 |
$85,079 |
D/D |
(5,395) |
88,822 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Financial Officer |
• – – |
2016-08-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,501 |
99,323 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Financial Officer |
• – – |
2016-10-11 |
4 |
AS |
$18.52 |
$46,300 |
D/D |
(2,500) |
96,823 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Financial Officer |
• – – |
2016-10-12 |
4 |
AS |
$16.41 |
$41,025 |
D/D |
(2,500) |
94,323 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Financial Officer |
• – – |
2016-11-10 |
4 |
AS |
$20.30 |
$50,750 |
D/D |
(2,500) |
91,823 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Financial Officer |
• – – |
2016-11-11 |
4 |
AS |
$19.37 |
$48,425 |
D/D |
(2,500) |
89,323 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Financial Officer |
• – – |
2016-11-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,503 |
99,826 |
0 |
- |
|
| ENWV |
Endwave Corp |
Director |
– • – |
2005-07-29 |
4 |
OE |
$19.30 |
$42,460 |
D/D |
2,200 |
2,200 |
|
- |
|
| ENWV |
Endwave Corp |
Director |
– • – |
2005-07-29 |
4 |
S |
$35.77 |
$78,694 |
D/D |
(2,200) |
0 |
|
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP & Chief Financial Officer |
• – – |
2017-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
49,500 |
149,326 |
0 |
- |
|
76 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
